Mersana Therapeutics Stock Forecast - Accumulation Distribution
| MRSN Stock | USD 2.19 0.02 0.92% |
Mersana Stock Forecast is based on your current time horizon. Although Mersana Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Mersana Therapeutics' systematic risk associated with finding meaningful patterns of Mersana Therapeutics fundamentals over time.
Mersana |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 33410.69 | 90312.15 |
| Check Mersana Therapeutics Volatility | Backtest Mersana Therapeutics | Trend Details |
Mersana Therapeutics Trading Date Momentum
| On September 04 2024 Mersana Therapeutics was traded for 1.44 at the closing time. The top price for the day was 1.48 and the lowest listed price was 1.39 . The trading volume for the day was 475.8 K. The trading history from September 4, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.69% . The trading delta at closing time against the current closing price is 6.90% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Mersana Therapeutics to competition |
Other Forecasting Options for Mersana Therapeutics
For every potential investor in Mersana, whether a beginner or expert, Mersana Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Mersana Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Mersana. Basic forecasting techniques help filter out the noise by identifying Mersana Therapeutics' price trends.View Mersana Therapeutics Related Equities
| Risk & Return | Correlation |
Mersana Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Mersana Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Mersana Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Mersana Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Mersana Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mersana Therapeutics shares will generate the highest return on investment. By undertsting and applying Mersana Therapeutics stock market strength indicators, traders can identify Mersana Therapeutics entry and exit signals to maximize returns.
Mersana Therapeutics Risk Indicators
The analysis of Mersana Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mersana Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mersana stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.85 | |||
| Semi Deviation | 5.09 | |||
| Standard Deviation | 6.62 | |||
| Variance | 43.83 | |||
| Downside Variance | 34.22 | |||
| Semi Variance | 25.89 | |||
| Expected Short fall | (5.88) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Mersana Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mersana Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Mersana Stock
| 0.64 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
Moving against Mersana Stock
| 0.62 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.61 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.61 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.6 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.6 | PIRS | Pieris Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Mersana Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mersana Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mersana Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mersana Therapeutics to buy it.
The correlation of Mersana Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mersana Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mersana Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mersana Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Mersana Therapeutics to cross-verify your projections. To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mersana Therapeutics. If investors know Mersana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mersana Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.286 | Quarterly Revenue Growth 0.637 | Return On Assets (0.26) | Return On Equity (2.13) |
The market value of Mersana Therapeutics is measured differently than its book value, which is the value of Mersana that is recorded on the company's balance sheet. Investors also form their own opinion of Mersana Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mersana Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mersana Therapeutics' market value can be influenced by many factors that don't directly affect Mersana Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mersana Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mersana Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mersana Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.